These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11798136)

  • 1. Mycobacterium-specific human CD8 T cell responses.
    Klein MR; Fox A
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):379-89. PubMed ID: 11798136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T lymphocytes against mycobacterium tuberculosis.
    Klein MR; McAdam KP
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):313-20. PubMed ID: 10604237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
    Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
    J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
    Romano M; Rindi L; Korf H; Bonanni D; Adnet PY; Jurion F; Garzelli C; Huygen K
    Vaccine; 2008 Nov; 26(48):6053-63. PubMed ID: 18822333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to identification of antigens of Mycobacterium tuberculosis.
    Wallis RS
    Infect Agents Dis; 1996 Mar; 5(2):119-25. PubMed ID: 8721048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.
    Mustafa AS
    Tuberculosis (Edinb); 2005; 85(5-6):367-76. PubMed ID: 16253561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2 complex controls CD4/CD8 ratio, recurrent responsiveness to repeated stimulations, and resistance to activation-induced apoptosis during T cell response to mycobacterial antigens.
    Pichugin AV; Petrovskaya SN; Apt AS
    J Leukoc Biol; 2006 Apr; 79(4):739-46. PubMed ID: 16415170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung.
    Hashimoto D; Nagata T; Uchijima M; Seto S; Suda T; Chida K; Miyoshi H; Nakamura H; Koide Y
    Vaccine; 2008 Sep; 26(40):5095-100. PubMed ID: 18514976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis--specific CD8+ T cells.
    Lewinsohn DA; Lines RA; Lewinsohn DM
    Am J Respir Crit Care Med; 2002 Sep; 166(6):843-8. PubMed ID: 12231495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
    Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis.
    Vipond J; Clark SO; Hatch GJ; Vipond R; Marie Agger E; Tree JA; Williams A; Marsh PD
    Tuberculosis (Edinb); 2006; 86(3-4):218-24. PubMed ID: 16520093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis.
    Temmerman ST; Place S; Debrie AS; Locht C; Mascart F
    J Infect Dis; 2005 Jul; 192(2):226-32. PubMed ID: 15962217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.